Sustainability Policy
Basic Approach
The mission of the Taisho Pharmaceutical Group is "to contribute to society by creating and offering superior pharmaceuticals and health-related products as well as healthcare-related information and services in socially responsible ways that enrich people's lives by improving health and beauty." Guided by this mission, the Group aims to contribute to society through its business activities.
Taisho Pharmaceutical was founded in 1912 and celebrated its 110th anniversary in 2022.
We believe that we have a significant social responsibility and role as a company that has been in business for over 100 years. We also believe that meeting the expectations of these responsibilities will lead to the creation of new corporate value.
Due to the demand for sustainable corporate activities such as strict quality control and appropriate waste disposal which has been a part of the pharmaceuticals industry for many years, Taisho Pharmaceutical has pioneered a wide range of initiatives ahead of other companies, contributing sincerely to the achievement of a sustainable society.
Our concepts of taking good care of things, taking initiatives for the global environment, and investing in and developing human resources, as well as our ideas and initiatives for co-existence and coprosperity with society, are defined in our management philosophy and have become deeply rooted in our corporate culture.
In addition to the various activities conducted so far, the Taisho Pharmaceutical Group as a whole will tackle the current social issues raised in the SDGs, etc., through our core business activities, thereby enhancing the sustainability of both the company and society.
ESG Initiatives
The Taisho Pharmaceutical Group is implementing initiatives aimed at sustainability in order to achieve sustainable growth for society and improve corporate value over the medium to long term. We identify and examine issues in ESG fields, and formulate pertinent policies. On top of this, related divisions undertake efforts to resolve specific issues, thereby fulfilling the social responsibility demanded by stakeholders.
SDGs Initiatives
The Sustainable Development Goals (SDGs) are 17 goals comprising 169 targets to be achieved by 2030 that were adopted by the 2015 UN Summit and seek resolution to problems confronting the world, such as poverty, the environment and social justice.
As a pharmaceutical manufacturer, our goal at Taisho Pharmaceutical is to ensure good health and fulfilling lives for consumers.
The Taisho Pharmaceutical Group is committed to growing with its employees by solving consumers' problems
with regard to their health. In pursuing this quest, the Company finds particularly strong affinity with four of the Sustainable Development Goals (SDGs): Goal 3, good health and well-being; Goal 8, decent work and
economic growth; Goal 9, industry, innovation and infrastructure; and Goal 12, responsible consumption and
production. The Taisho Pharmaceutical Group is determined to contribute to the achievement of the SDGs through its business activities.
Initiatives Through Business Activities
The business domains of the Taisho Pharmaceutical Group consist of two groups: the Self-Medication Operation Group and the Prescription Pharmaceutical Operation Group. Thanks to the sheer variety of the products it handles on the theme of health, ranging from prescription pharmaceuticals to OTC drugs, health foods and cosmetics, the Group is in a unique position to offer solutions to social problems in each business domain.
As an example, we launched Coppertone Protection UV Plus Milk after research reported that certain ingredients in sunscreens were negatively impacting marine life and coral reefs. The sunscreen achieves a high effect of SPF50+, PA++++ without using the UV absorbers oxybenzone and octinoxate.
While natural disasters such as earthquakes, windstorms and floods in recent years have raised awareness of disaster prevention, there have also been issues related to stockpiled food such as water shortages, unbalanced nutrition, and insufficient supply of anti-allergic food when disasters occur. In response to these issues, we launched "Lipovitan JELLY for long-term storage," jelly type drink that is suitable for emergency stockpiling because of its special technology that enables long-term storage※ for 5 years.
In April 2022, the company received the "Emergency Foods Award 2022" award of excellence in the "Health and allergy category," sponsored by the Disaster Prevention Safety Association, which is awarded to emergency foods that can be eaten with peace of mind in terms of health and safety at the time of a disaster.
- ※ It has a shelf life of 5 years and 6 months at the time of m anufacturing.
Stakeholder Engagement
The Taisho Pharmaceutical Group continues to pursue sustainable growth in its business activities and recognizes the importance of fulfilling the following responsibilities expected by the various stakeholders.
| For consumers | The Company will strive to help realize healthier and more enriched lives based on the theme of health in various fields. |
|---|---|
| For business customers and suppliers | The Company will establish and maintain fair and reasonable relationships. |
| For employees | The Company will respect the human rights and dignity of each individual and endeavor to secure employment. |
| For local communities | The Company will remain actively engaged in the community as a corporate citizen while striving to protect the environment and build mutually beneficial relationships. |
| For shareholders and other investors | The Company will disclose accurate information in a fair and timely manner. |
The Taisho Pharmaceutical Group strives to strengthen communication with stakeholders through a variety of means in order to identify their expectations and requirements of the Group in recognition of the importance of dialogue for getting stakeholders to understand the initiatives we are undertaking.
Respect of Human Rights
We clarify in the Global Compliance Guideline our stance toward respect of human rights and individuality as well as elimination of improper behavior that could infringe an individual's dignity (harassment) or lead to discrimination, and make this known to all employees.
In addition to eliminating discrimination based on gender, nationality, race, religion, age, belief, physical disabilities or other such factor, we are committed to avoiding acts that cause discomfort to others even though discrimination may not be intended. We also strive to eliminate forced labor, child labor and other forms of slave-type treatment.